Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

In a retrospective review of 105 patients treated exclusively with anti-Helicobacter therapy for locally confined gastric MALT lymphoma initial complete responses were achieved in 75% of cases and at a median follow-up of 6.3 years, disease relapse had occurred in only 13.

Long-term Outcomes for Anti-Helicobacter Treatment of Localized Gastric MALT Lymphoma